↧
GlaxoSmithKline posts loss of $616 million for 4th quarter as drugmaker...
GlaxoSmithKline posts loss of $616 million for 4th quarter as drugmaker continues integration and restructuring program - AP
View ArticlePharma giant GlaxoSmithKline says CEO Andrew Witty to retire in 2017 - Reuters
Pharma giant GlaxoSmithKline says CEO Andrew Witty to retire in 2017 - Reuters
View ArticleTop investor in GlaxoSmithKline calls for outside to replace current CEO...
Top investor in GlaxoSmithKline calls for outside to replace current CEO Andrew Witty - Reuters
View Article